» Articles » PMID: 27022967

Optical Coherence Tomography Angiography Study of Choroidal Neovascularization Early Response After Treatment

Overview
Journal Dev Ophthalmol
Publisher Karger
Specialty Ophthalmology
Date 2016 Mar 30
PMID 27022967
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Study the choroidal neovascularization (CNV) morphological evolution after treatment using optical coherence tomography angiography (OCTA).

Method: We used Optovue XR Avanti, with split-spectrum amplitude-decorrelation angiography algorithm.

Results: OCT Angiography allows to recognize better the CNV type. In our series all our cases seem to follow a 45 to 60 days cycle, after intra vitreal injection. After each injection a pruning of smaller vessels is seen immediately (after 24 hours) that increases for 6 to 12 days when it reaches a maximum. It is followed by a reopening or new sprouting of the vessels 20 to 50 days later. The later cycles seem longer. Our results on early CNV evolution seem to confirm previous observations of CNV abnormalization and arterialization. Pruning the small peripheral branches seems to strengthen the trunk. In OCTA, closing terminal vessels (anti-VEGF effects) seems to cause an increased flow in trunk after the CNV reactivation.

Citing Articles

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era.

Armendariz B, Chakravarthy U Eye (Lond). 2024; 38(17):3243-3251.

PMID: 39198703 PMC: 11584703. DOI: 10.1038/s41433-024-03308-6.


Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.

Fu Y, Zhang Z, Webster K, Paulus Y Biomolecules. 2024; 14(3).

PMID: 38540673 PMC: 10968528. DOI: 10.3390/biom14030252.


Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography.

Attarde A, Riad T, Zhang Z, Ahir M, Fu Y J Vis Exp. 2023; (198).

PMID: 37677008 PMC: 11655030. DOI: 10.3791/65682.


Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration.

Park J, Kim K, Kang M, Kim E, Yu S BMC Ophthalmol. 2023; 23(1):314.

PMID: 37438681 PMC: 10337201. DOI: 10.1186/s12886-023-03039-4.


Quantitative response of macular neovascularisation to loading phase of aflibercept in neovascular age-related macular degeneration.

Montesel A, Hagag A, Chandra S, Pakeer Muhammed R, Thottarath S, Chandak S Eye (Lond). 2023; 37(17):3648-3655.

PMID: 37258659 PMC: 10686403. DOI: 10.1038/s41433-023-02574-0.